Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Central Nervous System
  4. Back
  5. Myasthenia
  6. Myasthenia Gravis or Lambert-Eaton Myasthenia Syndrome, medicines that may affect patients (642)

Myasthenia Gravis or Lambert-Eaton Myasthenia Syndrome, medicines that may affect patients (642)

Warning

There are certain medicines that have been reported to worsen or induce myasthenia gravis (MG), often by increasing muscular weakness, and should be used with caution in patients with this condition. The list of medicines in table 1 has been compiled to assist prescribers in the decision making process when prescribing medicines for patients with myasthenia gravis.

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 19/03/2026

Next review date: 31/12/2028

Author(s): Laura Stobo.

Version: 3

Approved By: Medicines Utilisation Subcommittee of ADTC

Document Id: 642

References